DDInter1606 DDInter1676
Adrenergic beta-agonist used to control premature labor.
Siponimod, also known as _Mayzent_, by Novartis, is a new drug formulated for the management of Multiple Sclerosis (MS). It was approved by the FDA on March 26, 2019 and by Health Canada on February 20, 2020. This drug is considered a _sphingosine-1-phosphate (S1P) receptor modulator_ and is thought to play a role in suppressing the central nervous system inflammation that is associated with MS [FDA label]. Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system that is chronic and inflammatory, disrupting communication between the brain and other parts of the body. Most patients diagnosed with this illness experience their initial disease symptoms between the age of 20 to 40, often the most productive years of life. Symptoms may include but are not limited to fatigue, gait changes, bowel or bladder dysfunction, abnormal muscle twitching, vision disturbance, and depressing or mood swings. MS is one of the most common causes of neurological disability in young adults and is found to occur more frequently in women than in men.[A176474,L5792]
Ritodrine {u} (Compound) resembles {v} (Compound) Arformoterol
Ritodrine {u} (Compound) resembles {v} (Compound) Dobutamine
Ritodrine {u} (Compound) binds {v} (Gene) GALR3
Ritodrine {u} (Compound) upregulates {v} (Gene) TGFBR2
Ritodrine {u} (Compound) downregulates {v} (Gene) POLR2I
Ritodrine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Flunisolide
Ritodrine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Ciclesonide
Ritodrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Isoprenaline
Ritodrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Phenylpropanolamine
Ritodrine {u} may lead to a major life threatening interaction when taken with {v} Ivosidenib
Ritodrine (Compound) resembles Arformoterol (Compound)
Ritodrine (Compound) resembles Dobutamine (Compound)
Ritodrine (Compound) binds GALR3 (Gene)
Ritodrine (Compound) upregulates TGFBR2 (Gene)
Ritodrine (Compound) downregulates POLR2I (Gene)
Ritodrine may cause a minor interaction that can limit clinical effects when taken with Flunisolide
Ritodrine may cause a minor interaction that can limit clinical effects when taken with Ciclesonide
Ritodrine may cause a moderate interaction that could exacerbate diseases when taken with Isoprenaline
Ritodrine may cause a moderate interaction that could exacerbate diseases when taken with Phenylpropanolamine
Ritodrine may lead to a major life threatening interaction when taken with Ivosidenib